---
figid: PMC4174460__nihms621047f1
figlink: /pmc/articles/PMC4174460/figure/F1/
number: Figure 1
caption: The seven FDA-approved agents for the treatment of kidney cancer targeting
  the von Hippel–Lindau (VHL) tumour suppressor pathway.
pmcid: PMC4174460
papertitle: Treating advanced kidney cancer—miles to go before we sleep.
reftext: W. Marston Linehan, et al. Nat Rev Clin Oncol. ;10(11):614-615.
pmc_ranked_result_index: '70858'
pathway_score: 0.9234425
filename: nihms621047f1.jpg
figtitle: Seven FDA-approved agents for the treatment of kidney cancer targeting the
  von Hippel–Lindau (VHL) tumour suppressor pathway
year: ''
organisms: Homo sapiens
ndex: cfb5c882-df0c-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4174460__nihms621047f1.html
  '@type': Dataset
  description: The seven FDA-approved agents for the treatment of kidney cancer targeting
    the von Hippel–Lindau (VHL) tumour suppressor pathway.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ARNT2
  - PDGFRB
  - EPAS1
  - TGFA
  - PDGFRA
  - HIF3A
  - PDGFA
  - PDGFC
  - EGFR
  - HIF1A
  - VHL
  - VEGFA
  - VEGFB
  - VEGFD
  - PGF
  - PDGFB
  - ARNTL
  - FLT4
  - PDGFD
  - XRCC1
  - ARNT
  - KDR
  - VEGFC
  - MTOR
  - FLT1
  - Temsirolimus
  - Pazopanib
  - Cancer
genes:
- word: VHL/HIF
  symbol: HIF
  source: bioentities_symbol
  hgnc_symbol: ARNT2
  entrez: '9915'
- word: PDGFR
  symbol: PDGFR
  source: bioentities_symbol
  hgnc_symbol: PDGFRB
  entrez: '5159'
- word: VHL/HIF
  symbol: HIF
  source: bioentities_symbol
  hgnc_symbol: EPAS1
  entrez: '2034'
- word: TGF-a
  symbol: TGFA
  source: hgnc_symbol
  hgnc_symbol: TGFA
  entrez: '7039'
- word: PDGFR
  symbol: PDGFR
  source: bioentities_symbol
  hgnc_symbol: PDGFRA
  entrez: '5156'
- word: VHL/HIF
  symbol: HIF
  source: bioentities_symbol
  hgnc_symbol: HIF3A
  entrez: '64344'
- word: PDGF
  symbol: PDGF
  source: bioentities_symbol
  hgnc_symbol: PDGFA
  entrez: '5154'
- word: PDGF
  symbol: PDGF
  source: bioentities_symbol
  hgnc_symbol: PDGFC
  entrez: '56034'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: VHL/HIF
  symbol: HIF
  source: bioentities_symbol
  hgnc_symbol: HIF1A
  entrez: '3091'
- word: VHL/HIF
  symbol: VHL
  source: hgnc_symbol
  hgnc_symbol: VHL
  entrez: '7428'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFB
  entrez: '7423'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFD
  entrez: '2277'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: PGF
  entrez: '5228'
- word: PDGF
  symbol: PDGF
  source: bioentities_symbol
  hgnc_symbol: PDGFB
  entrez: '5155'
- word: VHL/HIF
  symbol: HIF
  source: bioentities_symbol
  hgnc_symbol: ARNTL
  entrez: '406'
- word: VEGFR
  symbol: VEGFR
  source: bioentities_symbol
  hgnc_symbol: FLT4
  entrez: '2324'
- word: PDGF
  symbol: PDGF
  source: bioentities_symbol
  hgnc_symbol: PDGFD
  entrez: '80310'
- word: RCC
  symbol: RCC
  source: hgnc_prev_symbol
  hgnc_symbol: XRCC1
  entrez: '7515'
- word: VHL/HIF
  symbol: HIF
  source: bioentities_symbol
  hgnc_symbol: ARNT
  entrez: '405'
- word: VEGFR
  symbol: VEGFR
  source: bioentities_symbol
  hgnc_symbol: KDR
  entrez: '3791'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFC
  entrez: '7424'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: VEGFR
  symbol: VEGFR
  source: bioentities_symbol
  hgnc_symbol: FLT1
  entrez: '2321'
chemicals:
- word: Temsirolimus
  source: MESH
  identifier: C401859
- word: Pazopanib
  source: MESH
  identifier: C516667
diseases:
- word: Cancer
  source: ''
  identifier: ''
---
